Zai Lab Grants 1.37 Million Share Options and 0.75 Million RSUs Under 2024 Equity Incentive Plan

Bulletin Express

Yesterday

Zai Lab Limited (HKEX: 09688; NASDAQ: ZLAB) has approved new equity awards aimed at retaining and incentivising key personnel.

• Share options – Grantee: 1 employee (senior manager) – ADSs granted: 136,819, representing 1.37 million ordinary shares – Exercise price: US$20.32 per ADS (≈ HK$15.85 per share), a 3.7% premium to the US$19.59 NASDAQ close on 11 May 2026 – Term & vesting: 10-year life; 25% vests on each anniversary of the grant date over four years, contingent on continued employment – No performance targets or claw-back provisions

• Restricted Share Units (RSUs) – Grantees: 4 employees (including one senior manager) – RSUs granted: 75,288 ADSs, equal to 0.75 million ordinary shares – Purchase price: nil – Vesting schedule: identical four-year, annual 25% vesting; subject to continued employment – No performance targets or claw-back provisions

Following these awards, 58.72 million shares remain available for future grants under Zai Lab’s 2024 Equity Incentive Plan, which was approved on 18 June 2024. The company confirmed that none of the grantees are directors, chief executives or substantial shareholders, and that individual grant limits under Hong Kong Listing Rules have not been exceeded.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1178938515"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1178938515\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1178938515?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-12 17:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1178938515","market":"hk","top_or_hot":-1,"title":"Zai Lab Grants 1.37 Million Share Options and 0.75 Million RSUs Under 2024 Equity Incentive Plan","media":"Bulletin Express","content":"<p>Zai Lab Limited (HKEX: 09688; NASDAQ: ZLAB) has approved new equity awards aimed at retaining and incentivising key personnel.</p>\n<p>• Share options  \n– Grantee: 1 employee (senior manager)  \n– ADSs granted: 136,819, representing 1.37 million ordinary shares  \n– Exercise price: US$20.32 per ADS (≈ HK$15.85 per share), a 3.7% premium to the US$19.59 NASDAQ close on 11 May 2026  \n– Term & vesting: 10-year life; 25% vests on each anniversary of the grant date over four years, contingent on continued employment  \n– No performance targets or claw-back provisions</p>\n<p>• Restricted Share Units (RSUs)  \n– Grantees: 4 employees (including one senior manager)  \n– RSUs granted: 75,288 ADSs, equal to 0.75 million ordinary shares  \n– Purchase price: nil  \n– Vesting schedule: identical four-year, annual 25% vesting; subject to continued employment  \n– No performance targets or claw-back provisions</p>\n<p>Following these awards, 58.72 million shares remain available for future grants under Zai Lab’s 2024 Equity Incentive Plan, which was approved on 18 June 2024. The company confirmed that none of the grantees are directors, chief executives or substantial shareholders, and that individual grant limits under Hong Kong Listing Rules have not been exceeded.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Zai Lab Grants 1.37 Million Share Options and 0.75 Million RSUs Under 2024 Equity Incentive Plan</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZai Lab Grants 1.37 Million Share Options and 0.75 Million RSUs Under 2024 Equity Incentive Plan\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-05-12 17:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Zai Lab Limited (HKEX: 09688; NASDAQ: ZLAB) has approved new equity awards aimed at retaining and incentivising key personnel.</p>\n<p>• Share options  \n– Grantee: 1 employee (senior manager)  \n– ADSs granted: 136,819, representing 1.37 million ordinary shares  \n– Exercise price: US$20.32 per ADS (≈ HK$15.85 per share), a 3.7% premium to the US$19.59 NASDAQ close on 11 May 2026  \n– Term & vesting: 10-year life; 25% vests on each anniversary of the grant date over four years, contingent on continued employment  \n– No performance targets or claw-back provisions</p>\n<p>• Restricted Share Units (RSUs)  \n– Grantees: 4 employees (including one senior manager)  \n– RSUs granted: 75,288 ADSs, equal to 0.75 million ordinary shares  \n– Purchase price: nil  \n– Vesting schedule: identical four-year, annual 25% vesting; subject to continued employment  \n– No performance targets or claw-back provisions</p>\n<p>Following these awards, 58.72 million shares remain available for future grants under Zai Lab’s 2024 Equity Incentive Plan, which was approved on 18 June 2024. The company confirmed that none of the grantees are directors, chief executives or substantial shareholders, and that individual grant limits under Hong Kong Listing Rules have not been exceeded.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09688","symbol_name":"再鼎医药","start_time":0,"source_url":"","article_id":"1178938515","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1178938515","pubTimestamp":1778576638,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Zai Lab Limited (HKEX: 09688; NASDAQ: ZLAB) has approved new equity awards aimed at retaining and incentivising key personnel. • Share options   – Grantee: 1 employee (senior manager)   – ADSs...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09688":"再鼎医药"},"translate_title":"再鼎医药根据2024年股权激励计划授予137万份股票期权和75万份受限制股份单位","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09688":1},"content_text":"Zai Lab Limited (HKEX: 09688; NASDAQ: ZLAB) has approved new equity awards aimed at retaining and incentivising key personnel.\n• Share options  \n– Grantee: 1 employee (senior manager)  \n– ADSs granted: 136,819, representing 1.37 million ordinary shares  \n– Exercise price: US$20.32 per ADS (≈ HK$15.85 per share), a 3.7% premium to the US$19.59 NASDAQ close on 11 May 2026  \n– Term & vesting: 10-year life; 25% vests on each anniversary of the grant date over four years, contingent on continued employment  \n– No performance targets or claw-back provisions\n• Restricted Share Units (RSUs)  \n– Grantees: 4 employees (including one senior manager)  \n– RSUs granted: 75,288 ADSs, equal to 0.75 million ordinary shares  \n– Purchase price: nil  \n– Vesting schedule: identical four-year, annual 25% vesting; subject to continued employment  \n– No performance targets or claw-back provisions\nFollowing these awards, 58.72 million shares remain available for future grants under Zai Lab’s 2024 Equity Incentive Plan, which was approved on 18 June 2024. The company confirmed that none of the grantees are directors, chief executives or substantial shareholders, and that individual grant limits under Hong Kong Listing Rules have not been exceeded.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}